Journal article
F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction and Suspected Coronary Disease A Randomized, Controlled Trial (PARR-2)
Abstract
OBJECTIVES: We conducted a randomized trial to assess the effectiveness of F-18-fluorodeoxyglucose (FDG) positron emission tomography (PET)-assisted management in patients with severe ventricular dysfunction and suspected coronary disease.
BACKGROUND: Such patients may benefit from revascularization, but have significant perioperative morbidity and mortality. F-18-fluorodeoxyglucose PET can detect viable myocardium that might recover after …
Authors
Beanlands RSB; Nichol G; Huszti E; Humen D; Racine N; Freeman M; Gulenchyn KY; Garrard L; deKemp R; Guo A
Journal
Journal of the American College of Cardiology, Vol. 50, No. 20, pp. 2002–2012
Publisher
Elsevier
Publication Date
November 2007
DOI
10.1016/j.jacc.2007.09.006
ISSN
0735-1097